X4 Pharmaceuticals, Inc. (XFOR) Operating income 2016–2025
X4 Pharmaceuticals, Inc. (XFOR) annual operating income history from SEC filings — each fiscal year as reported.
-$86.9MFY2025 · since FY2016: -$24.3M → -$86.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$86.9M | -138.7% |
| FY2024 | -$36.4M | +66.1% |
| FY2023 | -$107.5M | -22.8% |
| FY2022 | -$87.6M | -2.9% |
| FY2021 | -$85.1M | -42.1% |
| FY2020 | -$59.9M | -15.8% |
| FY2019 | -$51.7M | -77.8% |
| FY2018 | -$29.1M | -30.7% |
| FY2017 | -$22.2M | +8.6% |
| FY2016 | -$24.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice